{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-026348","form_type":"8-K","ticker":"PMHS","cik":"0001265521","company_name":"Polomar Health Services, Inc.","filed_at":"2024-07-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.422783+00:00","generated_at":"2026-05-31T23:17:36.574576+00:00","sec_items":["9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"Trustfeed Corp. licenses patent-pending IP from affiliate Pinata Holdings for drug delivery products","bullets":["Royalty rates: 10% for metformin, 15% for sumatriptan/sildenafil, 20% for semaglutide/liraglutide on net sales.","License is worldwide, non-exclusive, perpetual; termination for material breach or 180 days notice.","Intended use is in products after planned acquisition of Polomar Specialty Pharmacy, announced June 28, 2024.","Pinata Holdings is an affiliate of CWR 1, LLC, the company's majority shareholder (related party transaction).","License covers patent-pending IP and know-how for delivery of five active ingredients (metformin, sumatriptan, semaglutide, liraglutide, sildenafil)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-026348","json":"https://secwatch.observer/filing/0001493152-24-026348.json","markdown":"https://secwatch.observer/filing/0001493152-24-026348.md","text":"https://secwatch.observer/filing/0001493152-24-026348.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1265521/000149315224026348/0001493152-24-026348-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1265521/000149315224026348/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:17:36.574576+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}